PROBLEM: The association between subclinical hypothyroidism (SCH) and recurrent pregnancy loss (RPL) remains unclear. We evaluated whether SCH affects subsequent live births and whether levothyroxine is effective in improving the live birth rate in patients with RPL. METHOD OF STUDY: This observational cohort study included 1418 pregnancies of 1014 patients with a history of 2 or more pregnancy losses, who were euthyroid or had hypothyroidism, and had at least one subsequent pregnancy outcome. Some patients with SCH, as defined as a TSH >2.5mIU/L, were treated with levothyroxine and these comprised the levothyroxine group. The prevalence of SCH, subsequent live birth rates per patient and per pregnancy were compared among patients with SCH treated with and without levothyroxine and patients with euthyroid. RESULTS: The prevalence of SCH was 14.4 %. Subsequent live birth rates were 75.0 % for the levothyroxine group, 68.6 % for the untreated SCH group and 70.1 % for the euthyroid group. After excluding miscarriages with abnormal karyotypes, live birth rates were 89.2 %, 90.0 % and 91.1 %. The adjusted odds ratio (95%CI) was 0.95 (0.23-3.83) after controlling covariables when comparing SCH patients with and without treatment. The live birth rates per pregnancy were 93.1%, 85.7% and 90.9%, respectively. The adjusted OR was 0.95 (0.23-3.83). CONCLUSIONS: Levothyroxine has no effect on improving the live birth rate in patients with RPL associated with SCH. Treatment in patients with RPL and SCH raised TSH levels (2.5-10mIU/L) might not be beneficial in improving the live birth rate.
Levothyroxine and subclinical hypothyroidism in patients with recurrent pregnancy loss